LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $784,057 | -5.7% | 16,260 | -2.3% | 0.02% | -19.4% |
| Q4 2022 | $831,218 | +24.8% | 16,651 | -1.7% | 0.03% | +40.9% |
| Q3 2022 | $666,000 | -35.8% | 16,945 | -10.2% | 0.02% | -29.0% |
| Q2 2022 | $1,037,000 | -4.9% | 18,866 | -37.1% | 0.03% | +10.7% |
| Q1 2022 | $1,090,000 | -13.5% | 29,995 | +10.9% | 0.03% | -15.2% |
| Q4 2021 | $1,260,000 | -39.5% | 27,043 | -34.4% | 0.03% | -47.6% |
| Q3 2021 | $2,084,000 | +6.5% | 41,212 | -13.5% | 0.06% | +6.8% |
| Q2 2021 | $1,956,000 | -0.2% | 47,656 | -29.4% | 0.06% | -10.6% |
| Q1 2021 | $1,959,000 | +6.8% | 67,489 | +3.6% | 0.07% | -12.0% |
| Q4 2020 | $1,835,000 | +42.7% | 65,162 | +56.4% | 0.08% | +17.2% |
| Q3 2020 | $1,286,000 | -17.7% | 41,673 | +13.4% | 0.06% | -22.0% |
| Q2 2020 | $1,563,000 | – | 36,735 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |